Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week ...
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback